Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jongen-Lavrencic, Mojca"'
Autor:
Bras AE; Laboratory Medical Immunology (LMI), Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Osmani Z; Laboratory Medical Immunology (LMI), Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., de Haas V; Dutch Childhood Oncology Group, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Te Marvelde JG; Laboratory Medical Immunology (LMI), Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Mejstrikova E; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., Fernandez P; Institute for Laboratory Medicine, Kantonsspital Aarau AG, Aarau, Switzerland., Szczepanski T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia (SUM), Katowice, Poland., Orfao A; Cancer Research Center (IBMCC-CSIC), Department of Medicine and Cytometry Service, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigaciόn Biomédicaen Red de Cáncer, Instituto Carlos III, Madrid, Spain., van Dongen JJM; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van der Velden VHJ; Laboratory Medical Immunology (LMI), Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 Jun; Vol. 193 (5), pp. 922-927. Date of Electronic Publication: 2020 Nov 07.
Autor:
Bras AE; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Beishuizen A; Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jongen-Lavrencic M; Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Te Marvelde JG; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Zwaan CM; Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands., van Dongen JJM; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
British journal of haematology [Br J Haematol] 2018 Jan; Vol. 180 (2), pp. 292-296. Date of Electronic Publication: 2016 Sep 08.
Autor:
Schwarzer A; Institute of Experimental Hematology, Hannover Medical School, Hannover, 30625, Germany.; Clinic for Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Hannover Medical School, Hannover, 30625, Germany., Emmrich S; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Schmidt F; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Beck D; Lowy Cancer Research Centre and the Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia.; Centre for Health Technologies and the School of Software, University of Technology, Sydney, NSW, 2007, Australia., Ng M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Reimer C; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Adams FF; Institute of Experimental Hematology, Hannover Medical School, Hannover, 30625, Germany., Grasedieck S; Department of Internal Medicine III, University Hospital of Ulm, Ulm, 89081, Germany., Witte D; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Käbler S; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Wong JWH; Lowy Cancer Research Centre and the Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia., Shah A; Lowy Cancer Research Centre and the Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia., Huang Y; Lowy Cancer Research Centre and the Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia., Jammal R; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Maroz A; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center, Rotterdam, 3015, The Netherlands., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, 30625, Germany.; REBIRTH Cluster of Excellence, Hannover Medical School, Hannover, 30625, Germany., Kuchenbauer F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, 89081, Germany., Pimanda JE; Lowy Cancer Research Centre and the Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia.; Centre for Health Technologies and the School of Software, University of Technology, Sydney, NSW, 2007, Australia., Reinhardt D; Clinic for Pediatrics III, University Hospital Essen, Essen, 45122, Germany., Heckl D; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany., Klusmann JH; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, 30625, Germany. klusmann.jan-henning@mh-hannover.de.
Publikováno v:
Nature communications [Nat Commun] 2017 Aug 09; Vol. 8 (1), pp. 218. Date of Electronic Publication: 2017 Aug 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dinmohamed, Avinash G., Brink, Mirian, Visser, Otto, Sonneveld, Pieter, Loosdrecht, Arjan A., Jongen‐Lavrencic, Mojca, Greef, Georgine E.
Publikováno v:
British Journal of Haematology; Nov2015, Vol. 171 Issue 3, p436-439, 4p, 1 Chart, 1 Graph
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martha Arellano, Patrick J. Stiff, Geoffrey L. Uy, Sarah E. Church, Norbert Vey, Marianne Santaguida, Patrick Kaminker, Ibrahim Aldoss, Erin Fehr, Michael P. Rettig, Matthew C. Foster, Maya Kostova, Patrice Chevallier, John F. DiPersio, Peter H. Sayre, Anjali S. Advani, Erica K. Anderson, Kendra Sweet, Bob Löwenberg, Matthew J. Wieduwilt, Martin Wermke, Farhad Ravandi, Jayakumar Vadakekolathu, Ezio Bonvini, Michael Byrne, Mojca Jongen-Lavrencic, Emmanuel Gyan, Matteo Carrabba, Jan K Davidson-Moncada, John E. Godwin, Laura C. Michaelis, Gerwin Huls, Fabio Ciceri, Kenneth Jacobs, Sergio Rutella, Ouiam Bakkacha, Kristen Pettit, Christian Recher, Kathy M. Tran, Teia Curtis, Stefania Paolini, Jian Zhao, Roland B. Walter, Max S. Topp, Kuo Guo, Ashkan Emadi, John Muth, Harry P. Erba
Publikováno v:
Blood, 137(6), 751-762. American Society of Hematology
Blood
Blood, 137(6), 751-762. AMER SOC HEMATOLOGY
Blood
Blood, 137(6), 751-762. AMER SOC HEMATOLOGY
Approximately 50% of acute myeloid leukemia (AML) patients do not respond to induction therapy (primary induction failure [PIF]) or relapse after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05abb6f9a6e869b8ae72d0b4779e5546